|
1
|
Antoni S, Ferlay J, Soerjomataram I, Znaor
A, Jemal A and Bray F: Bladder cancer incidence and mortality: A
global overview and recent trends. Eur Urol. 71:96–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benhamou S, Bonastre J, Groussard K,
Radvanyi F, Allory Y and Lebret T: A prospective multicenter study
on bladder cancer: The COBLAnCE cohort. BMC Cancer. 16:8372016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Racioppi M, D'Agostino D, Totaro A, Pinto
F, Sacco E, D'Addessi A, Marangi F, Palermo G and Bassi PF: Value
of current chemotherapy and surgery in advanced and metastatic
bladder cancer. Urol Int. 88:249–258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blick C, Ramachandran A, McCormick R,
Wigfield S, Cranston D, Catto J and Harris AL: Identification of a
hypoxia-regulated miRNA signature in bladder cancer and a role for
miR-145 in hypoxia-dependent apoptosis. Br J Cancer. 113:634–644.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Rhijn BW, Burger M, Lotan Y, Solsona
E, Stief CG, Sylvester RJ, Witjes JA and Zlotta AR: Recurrence and
progression of disease in non-muscle-invasive bladder cancer: From
epidemiology to treatment strategy. Eur Urol. 56:430–442. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng Y, Li Z, Xie J, Wang P, Zhu J, Li Y
and Wang Y: MiRNA-224-5p inhibits autophagy in breast cancer cells
via targeting Smad4. Biochem Biophys Res Commun. 506:793–798. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vishnoi A and Rani S: MiRNA biogenesis and
regulation of diseases: An overview. Methods Mol Biol. 1509:1–10.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang N, Wu J, Qiu W, Lyu Q, He J, Xie W,
Xu N and Zhang Y: MiR-15a and miR-16 induce autophagy and enhance
chemosensitivity of camptothecin. Cancer Biol Ther. 16:941–948.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang QQ, Liu B and Yuan T: MicroRNA-16
inhibits bladder cancer proliferation by targeting Cyclin D1. Asian
Pac J Cancer Prev. 14:4127–4130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Zhang Y, Wu Q, Wang YB and Wang W:
miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal
transition via activation of autophagy in non-small cell lung
carcinoma cells. Oncol Rep. 39:247–254. 2018.PubMed/NCBI
|
|
13
|
Xia ZX, Li ZX, Zhang M, Sun LM, Zhang QF
and Qiu XS: CARMA3 regulates the invasion, migration, and apoptosis
of non-small cell lung cancer cells by activating NF-кB and
suppressing the P38 MAPK signaling pathway. Exp Mol Pathol.
100:353–360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang S, Zhang C, Liu W, Zheng W, Zhang Y,
Wang S, Huang D, Liu X and Bai Z: MicroRNA-24 upregulation inhibits
proliferation, metastasis and induces apoptosis in bladder cancer
cells by targeting CARMA3. Int J Oncol. 47:1351–1360. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Patel M, Horgan PG, McMillan DC and
Edwards J: NF-κB pathways in the development and progression of
colorectal cancer. Transl Res. 197:43–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Kuang Y, Wang Y, Xu Q and Ren Q:
Notch-4 silencing inhibits prostate cancer growth and EMT via the
NF-κB pathway. Apoptosis. 22:877–884. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C, Li A, Yang S, Qiao R, Zhu X and
Zhang J: CXCL5 promotes mitomycin C resistance in non-muscle
invasive bladder cancer by activating EMT and NF-κB pathway.
Biochem Biophys Res Commun. 498:862–868. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao G: Autophagy and NF-kappaB: Fight for
fate. Cytokine Growth Factor Rev. 18:233–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu W, Chen SS, Zhang JL, Lou XE and Zhou
HJ: Dihydroartemisinin induces autophagy by suppressing NF-κB
activation. Cancer Lett. 343:239–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He HJ, Bing H and Liu G: TSR2 Induces
laryngeal cancer cell apoptosis through inhibiting NF-κB signaling
pathway. Laryngoscope. 128:E130–E134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Research Council, . Committee for
the Update of the Guide for the Care and Use of Laboratory Animals.
Guide for the Care and Use of Laboratory Animals. 8th edition.
National Academies Press; Washington, DC: 2011, PubMed/NCBI
|
|
23
|
Wang F, Wu H, Fan M, Yu R, Zhang Y, Liu J,
Zhou X, Cai Y, Huang S, Hu Z and Jin X: Sodium butyrate inhibits
migration and induces AMPK-mTOR pathway-dependent autophagy and
ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human
bladder cancer cells. FASEB J. 34:4266–4282. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu X, Li S, Li Y, Cheng B, Tan B and Wang
G: Puerarin inhibits proliferation and induces apoptosis by
upregulation of miR-16 in bladder cancer cell line T24. Oncol Res.
26:1227–1234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
White E, Mehnert JM and Chan CS:
Autophagy, metabolism, and cancer. Clin Cancer Res. 21:5037–5046.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Won SJ, Yen CH, Liu HS, Wu SY, Lan SH,
Jiang-Shieh YF, Lin CN and Su CL: Justicidin A-induced autophagy
flux enhances apoptosis of human colorectal cancer cells via class
III PI3K and Atg5 pathway. J Cell Physiol. 230:930–946. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan S, Yang X, Chen T, Xi Z and Jiang X:
The PPARγ agonist Troglitazone induces autophagy, apoptosis and
necroptosis in bladder cancer cells. Cancer Gene Ther. 21:188–193.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maiuri MC, Le Toumelin G, Criollo A, Rain
JC, Gautier F, Juin P, Tasdemir E, Pierron G, Troulinaki K,
Tavernarakis N, et al: Functional and physical interaction between
Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26:2527–2539.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Galonek HL and Hardwick JM: Upgrading the
BCL-2 network. Nat Cell Biol. 8:1317–1319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao T, Miao Z, Wang Z, Xu Y, Wu J, Liu X,
You Y and Li J: CARMA3 overexpression accelerates cell
proliferation and inhibits paclitaxel-induced apoptosis through
NF-κB regulation in breast cancer cells. Tumour Biol. 34:3041–3047.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Man X, Liu T, Jiang Y, Zhang Z, Zhu Y, Li
Z, Kong C and He J: Silencing of CARMA3 inhibits bladder cancer
cell migration and invasion via deactivating β-catenin signaling
pathway. Onco Targets Ther. 12:6309–6322. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Qian L, Li X and Yan J:
MicroRNA-195 inhibits colorectal cancer cell proliferation,
colony-formation and invasion through targeting CARMA3. Mol Med
Rep. 10:473–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Man X, He J, Kong C, Zhu Y and Zhang Z:
Clinical significance and biological roles of CARMA3 in human
bladder carcinoma. Tumour Biol. 35:4131–4136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia Y, Shen S and Verma IM: NF-κB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Naugler WE and Karin M: NF-kappaB and
cancer-identifying targets and mechanisms. Curr Opin Genet Dev.
18:19–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yan W, Ma X, Zhao X and Zhang S: Baicalein
induces apoptosis and autophagy of breast cancer cells via
inhibiting PI3K/AKT pathway in vivo and vitro. Drug Des Devel Ther.
12:3961–3972. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ruan L and Qian X: MiR-16-5p inhibits
breast cancer by reducing AKT3 to restrain NF-κB pathway. Biosci
Rep. Aug 23–2019.(Epub ahead of print). doi: 10.1042/BSR20191611.
View Article : Google Scholar
|
|
39
|
Paul-Samojedny M, Pudelko A, Kowalczyk M,
Fila-Daniłow A, Suchanek-Raif R, Borkowska P and Kowalski J:
Knockdown of AKT3 and PI3KCA by RNA interference changes the
expression of the genes that are related to apoptosis and autophagy
in T98G glioblastoma multiforme cells. Pharmacol Rep. 67:1115–1123.
2015. View Article : Google Scholar : PubMed/NCBI
|
